Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications

The Food and Drug Administration (FDA) is requesting approval of a new generic for collecting information through the use of qualitative methods for studies about tobacco products. FDA will employ qualitative research, including individual in-depth interviews (IDIs), small group discussions, and focus groups to explore knowledge and perceptions about tobacco-related topics with specific target audiences. FDA will only submit an individual generic collection for approval under this generic clearance if the individual collection meets the outlined conditions.

The latest form for Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications expires 2028-03-31 and is listed under ICR 202406-0910-003.